Derya Özdoğru, F. Salkın, Elif Banu Söker, O. Uysal
Objective: Data on cardiovascular dysfunction is limited in the previous literature on patients with multiple sclerosis. In this study, we aimed to elucidate the cardiovascular parameters in multiple sclerosis patients by comparing the systolic-diastolic functions and atrial electro-mechanical delay compared to the control group. Method: A total of 37 patients with a diagnosis of relapsing-remitting multiple sclerosis and had Expanded Disability Status Scale (EDSS) scores between 0 – 3, and 20 individuals in the control group were included in the study. Seventeen of the MS patients (n=17) were taking immunomodulatory drugs and the other 20 did not receive any immunomodulatory agents. Patients with a diagnosis or clinical suspicion of cardiac dysfunction and using cardiotoxic medications were excluded. The measurement of systolic and diastolic function parameters was performed via M – Mode 2D transthoracic echocardiography, and Atrial electro-mechanical delay (AEMD) measurements were performed with tissue Doppler. Results: E’ MV lateral and MV E/A values were determined to be higher in MS patients, who did not use immunomodulatory drugs, compared to the control group (p<0.001, p=0.010 respectively). E/E’ MV lateral and MV AVmax values were determined to be significantly higher in the patient group using immunomodulators compared to the other two groups (p=0.009, p=0.012 respectively). PAs, PAI, left and right intraatrial EMG values were determined to be prolonged in MS patients using and not using drugs compared to the control group, but these values were not determined to be statistically significant. Conclusion: We found that left ventricular diastolic function was impaired in MS patients compared to the control group, and right-left intra- and interatrial AEMD were similar. Based on these results, we recommend echocardiographic assessment for early detection of left ventricular diastolic dysfunction in MS patients.
{"title":"Assessment of atrial electromechanical delay and echocardiographic parameters in patients with multiple sclerosis","authors":"Derya Özdoğru, F. Salkın, Elif Banu Söker, O. Uysal","doi":"10.54029/2023yjr","DOIUrl":"https://doi.org/10.54029/2023yjr","url":null,"abstract":"Objective: Data on cardiovascular dysfunction is limited in the previous literature on patients with multiple sclerosis. In this study, we aimed to elucidate the cardiovascular parameters in multiple sclerosis patients by comparing the systolic-diastolic functions and atrial electro-mechanical delay compared to the control group. Method: A total of 37 patients with a diagnosis of relapsing-remitting multiple sclerosis and had Expanded Disability Status Scale (EDSS) scores between 0 – 3, and 20 individuals in the control group were included in the study. Seventeen of the MS patients (n=17) were taking immunomodulatory drugs and the other 20 did not receive any immunomodulatory agents. Patients with a diagnosis or clinical suspicion of cardiac dysfunction and using cardiotoxic medications were excluded. The measurement of systolic and diastolic function parameters was performed via M – Mode 2D transthoracic echocardiography, and Atrial electro-mechanical delay (AEMD) measurements were performed with tissue Doppler. Results: E’ MV lateral and MV E/A values were determined to be higher in MS patients, who did not use immunomodulatory drugs, compared to the control group (p<0.001, p=0.010 respectively). E/E’ MV lateral and MV AVmax values were determined to be significantly higher in the patient group using immunomodulators compared to the other two groups (p=0.009, p=0.012 respectively). PAs, PAI, left and right intraatrial EMG values were determined to be prolonged in MS patients using and not using drugs compared to the control group, but these values were not determined to be statistically significant. Conclusion: We found that left ventricular diastolic function was impaired in MS patients compared to the control group, and right-left intra- and interatrial AEMD were similar. Based on these results, we recommend echocardiographic assessment for early detection of left ventricular diastolic dysfunction in MS patients.","PeriodicalId":49757,"journal":{"name":"Neurology Asia","volume":"45 2","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139194122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Some evidence suggests that given the limited healthcare resources, the majority of low- risk stroke patients may not require critical care monitoring. This study aimed to establish a predictive score for identifying post-intravenous thrombolysis (IVT) acute ischemic stroke patients who should be monitored in the intensive care unit (ICU). Methods: This was a retrospective cohort study of patients with acute ischemic stroke who underwent IVT at Songklanagarind Hospital, Thailand between January 2010 and December 2019. Baseline characteristics and clinical outcomes were recorded. Systolic blood pressure (SBP) was collected using the first recorded in the emergency department (ED) as well as the National Institutes of Health Stroke Scale (NIHSS). Results: Of the 171 patients with stroke, 73 (42.7%) needed ICU care. The median age was 67 years old. The median SBP and NIHSS were 160 mm Hg and 10, respectively. The predicting stroke ICU (PSU) score was developed, with the following points assigned: NIHSS score (1 point if > 9), SBP (1 point if > 170 mmHg), and infarct size greater than 1 lobe (2 points if present). The PSU score achieved an area under the ROC curve of 0.759 (95% confidence interval [CI] = 0.688–0.830). A PSU score ≥ 1 predicted the need for ICU care with a sensitivity of 91.78%. Conclusions: The PSU score, which is based on the NIHSS score, systolic blood pressure, and infarct size, predicts the need for ICU care after IVT in patients with stroke.
{"title":"Intensive care unit admission prediction tool for ischemic stroke patients receiving intravenous thrombolysis: A retrospective cohort study","authors":"Chinarong Tiyadechachai, Veerapong Vattanavanit","doi":"10.54029/2023nyd","DOIUrl":"https://doi.org/10.54029/2023nyd","url":null,"abstract":"Background: Some evidence suggests that given the limited healthcare resources, the majority of low- risk stroke patients may not require critical care monitoring. This study aimed to establish a predictive score for identifying post-intravenous thrombolysis (IVT) acute ischemic stroke patients who should be monitored in the intensive care unit (ICU). Methods: This was a retrospective cohort study of patients with acute ischemic stroke who underwent IVT at Songklanagarind Hospital, Thailand between January 2010 and December 2019. Baseline characteristics and clinical outcomes were recorded. Systolic blood pressure (SBP) was collected using the first recorded in the emergency department (ED) as well as the National Institutes of Health Stroke Scale (NIHSS). Results: Of the 171 patients with stroke, 73 (42.7%) needed ICU care. The median age was 67 years old. The median SBP and NIHSS were 160 mm Hg and 10, respectively. The predicting stroke ICU (PSU) score was developed, with the following points assigned: NIHSS score (1 point if > 9), SBP (1 point if > 170 mmHg), and infarct size greater than 1 lobe (2 points if present). The PSU score achieved an area under the ROC curve of 0.759 (95% confidence interval [CI] = 0.688–0.830). A PSU score ≥ 1 predicted the need for ICU care with a sensitivity of 91.78%. Conclusions: The PSU score, which is based on the NIHSS score, systolic blood pressure, and infarct size, predicts the need for ICU care after IVT in patients with stroke.","PeriodicalId":49757,"journal":{"name":"Neurology Asia","volume":"11 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139189573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Myasthenia gravis (MG) is associated with reduced health-related quality of life (HRQOL). This study aimed to investigate factors that impact HRQOL in MG in a patient population in West China. Methods: A series of questionnaires were completed by 168 patients to assess the relationships between HRQOL and social support and coping style. We also evaluated the contributions of clinical characteristics to HRQOL. One-way analysis of variance (ANOVA), correlation and regression analysis were conducted to identify predictors that negatively impact HRQOL in MG. Results: There were significant differences in HRQOL scores among patients with different ratio of disease cost to income each month (F = 5.831, P = 0.001) and frequency of MG symptoms (F = 9.128, P < 0.001). Spearman’s correlation analysis showed that reduced HRQOL had low correlation with Myasthenia Gravis Composite score (r = 0.461, P < 0.001), confrontation (r = 0.312, P < 0.001) and acceptance- resignation coping style (r = 0.433, P < 0.001). Stepwise regression analysis further revealed that acceptance-resignation coping style (β = 0.380, P < 0.001) and MGC score (β = 0.322, P < 0.001) were the main predictors of HRQOL. Conclusions: Our study revealed the factors that impact HRQOL in MG patients and provided the first demonstration that acceptance-resignation is the main independent predictor of poor HRQOL in MG, other than disease severity.
{"title":"Factors that impact health-related quality of life in 168 myasthenia gravis in West China: Disease severity, social support, and coping style","authors":"X. Miao, Hongxi Chen, Zi-yan Shi","doi":"10.54029/2023uyw","DOIUrl":"https://doi.org/10.54029/2023uyw","url":null,"abstract":"Background: Myasthenia gravis (MG) is associated with reduced health-related quality of life (HRQOL). This study aimed to investigate factors that impact HRQOL in MG in a patient population in West China. Methods: A series of questionnaires were completed by 168 patients to assess the relationships between HRQOL and social support and coping style. We also evaluated the contributions of clinical characteristics to HRQOL. One-way analysis of variance (ANOVA), correlation and regression analysis were conducted to identify predictors that negatively impact HRQOL in MG. Results: There were significant differences in HRQOL scores among patients with different ratio of disease cost to income each month (F = 5.831, P = 0.001) and frequency of MG symptoms (F = 9.128, P < 0.001). Spearman’s correlation analysis showed that reduced HRQOL had low correlation with Myasthenia Gravis Composite score (r = 0.461, P < 0.001), confrontation (r = 0.312, P < 0.001) and acceptance- resignation coping style (r = 0.433, P < 0.001). Stepwise regression analysis further revealed that acceptance-resignation coping style (β = 0.380, P < 0.001) and MGC score (β = 0.322, P < 0.001) were the main predictors of HRQOL. Conclusions: Our study revealed the factors that impact HRQOL in MG patients and provided the first demonstration that acceptance-resignation is the main independent predictor of poor HRQOL in MG, other than disease severity.","PeriodicalId":49757,"journal":{"name":"Neurology Asia","volume":"284 ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139195263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K. Narasimhalu, Joel Soo, Jia Yi Shen, Pei Shieen Wong
Pharmacogenomics has emerged as a tool to optimise treatment. Many neurologists encounter drugs with pharmacogenomic associations with unclear guidelines. We therefore aimed to determine the knowledge, attitudes, and barriers to implementing pharmacogenomics in clinical practice within a neurology unit. We developed and administered a survey on pharmacogenomics to physicians working in a neurology unit. Three drug-gene pairs clinically relevant to neurology were presented as case scenarios to assess physicians’ perceived competency, attitudes, and risks towards pharmacogenomics. Thirty-two (27.4%) physicians responded to the survey. Respondents were most confident about activities involving the HLA-B*15:02 test, followed by the CYP2C19 test, and lastly the CYP2C9 test. However, perceived competency in drug-drug-gene interactions was consistently low for all three tests. Referring to the product information leaflet ranked highest in usefulness, followed by local practice guidelines. In conclusion, local clinical guidelines and training on the clinical applications of pharmacogenomics are important to facilitate the implementation of pharmacogenomics.
{"title":"Pharmacogenomics knowledge within Neurology: A brief survey amongst physicians","authors":"K. Narasimhalu, Joel Soo, Jia Yi Shen, Pei Shieen Wong","doi":"10.54029/2023xfs","DOIUrl":"https://doi.org/10.54029/2023xfs","url":null,"abstract":"Pharmacogenomics has emerged as a tool to optimise treatment. Many neurologists encounter drugs with pharmacogenomic associations with unclear guidelines. We therefore aimed to determine the knowledge, attitudes, and barriers to implementing pharmacogenomics in clinical practice within a neurology unit. We developed and administered a survey on pharmacogenomics to physicians working in a neurology unit. Three drug-gene pairs clinically relevant to neurology were presented as case scenarios to assess physicians’ perceived competency, attitudes, and risks towards pharmacogenomics. Thirty-two (27.4%) physicians responded to the survey. Respondents were most confident about activities involving the HLA-B*15:02 test, followed by the CYP2C19 test, and lastly the CYP2C9 test. However, perceived competency in drug-drug-gene interactions was consistently low for all three tests. Referring to the product information leaflet ranked highest in usefulness, followed by local practice guidelines. In conclusion, local clinical guidelines and training on the clinical applications of pharmacogenomics are important to facilitate the implementation of pharmacogenomics.","PeriodicalId":49757,"journal":{"name":"Neurology Asia","volume":"48 3","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139191618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fedrick Tandiawan, Suryani Gunadharma, U. Gamayani, Anam Ong, Ahmad Rizal Ganiem, Sobaryati, Shelly Iskandar
Background: Depressive disorder is a common psychiatric comorbidity in patients with epilepsy (PWE). This health condition is prevalent among the Sundanese who have a calm and polite character, with a tendency to hide their feelings, which is associated with an increased risk of depression. Methods: This cross-sectional study aimed to determine the prevalence of major depressive disorder (MDD) and the associated factors among Sundanese PWE. The study was carried out in the neurology outpatient clinic at Hasan Sadikin General Hospital Bandung, consisting of the Sunda ethnic group as the majority of patients. Self-stigma degree was measured using the Indonesian version of Internalized Stigma of Epilepsy (ISEP) questionnaire, while depression symptom was screened through the Indonesian version of Neurological Disorders Depression Inventory for Epilepsy (NDDI-E). Subsequently, patients who had depression symptoms were referred to a psychiatrist to confirm whether their conditions matched the criteria of MDD according to the Diagnostic and Statistical Manual of Mental Disorder-5. Results: The prevalence of depressive symptoms in Sundanese epilepsy patients was found to be 18.4%, and MDD was 6.8% among 103 patients included in this study. Many PWE with MDD were not married, had uncontrolled seizures, used polytherapy anti-seizure medication, and exhibited a higher degree of self-stigma. Conclusion: In this study, the prevalence of MDD was found to be 6.8% among a cohort of Sundanese PWE. A significant relationship was also observed between MDD and several factors, including single status, uncontrolled seizure, polytherapy, and a higher degree of self-stigma.
{"title":"Depression as comorbidity in Sundanese epilepsy patients","authors":"Fedrick Tandiawan, Suryani Gunadharma, U. Gamayani, Anam Ong, Ahmad Rizal Ganiem, Sobaryati, Shelly Iskandar","doi":"10.54029/2023xmy","DOIUrl":"https://doi.org/10.54029/2023xmy","url":null,"abstract":"Background: Depressive disorder is a common psychiatric comorbidity in patients with epilepsy (PWE). This health condition is prevalent among the Sundanese who have a calm and polite character, with a tendency to hide their feelings, which is associated with an increased risk of depression. Methods: This cross-sectional study aimed to determine the prevalence of major depressive disorder (MDD) and the associated factors among Sundanese PWE. The study was carried out in the neurology outpatient clinic at Hasan Sadikin General Hospital Bandung, consisting of the Sunda ethnic group as the majority of patients. Self-stigma degree was measured using the Indonesian version of Internalized Stigma of Epilepsy (ISEP) questionnaire, while depression symptom was screened through the Indonesian version of Neurological Disorders Depression Inventory for Epilepsy (NDDI-E). Subsequently, patients who had depression symptoms were referred to a psychiatrist to confirm whether their conditions matched the criteria of MDD according to the Diagnostic and Statistical Manual of Mental Disorder-5. Results: The prevalence of depressive symptoms in Sundanese epilepsy patients was found to be 18.4%, and MDD was 6.8% among 103 patients included in this study. Many PWE with MDD were not married, had uncontrolled seizures, used polytherapy anti-seizure medication, and exhibited a higher degree of self-stigma. Conclusion: In this study, the prevalence of MDD was found to be 6.8% among a cohort of Sundanese PWE. A significant relationship was also observed between MDD and several factors, including single status, uncontrolled seizure, polytherapy, and a higher degree of self-stigma.","PeriodicalId":49757,"journal":{"name":"Neurology Asia","volume":"50 4","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139191884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Christine Audrey, Kheng Seang Lim, Chet-Ying Chan, Thinisha Sathis Kumar, Rui Jia Hou, Si-Lei Fong, Vairavan Narayanan, Wan Muhammad Afnan Wan Anuar, Chong-Tin Tan
Objective: We aimed to determine the cumulative seizure occurrence, 1-year, and 5-years of preoperative seizures in gliomas, and an update on the predictors. Methods: This was a retrospective analysis of 239 patients with histopathologically confirmed gliomas in University Malaya Medical Centre, Malaysia, between 2008-2020. Kaplan-Meier curves were used to determine the cumulative incidence of seizures. Logistic regression was performed to determine the predictors of preoperative seizures. Results: A total of 80/239 patients (33.5%) had preoperative seizures. They were more commonly seen in those with younger age of presentation (40.0% in those <40 years old vs. 26.9% in ≥40 years old, p<0.05) and low-grade tumors (42.2% vs. 28.8% in high-grade tumors). Those with cortical involvement, especially the frontal lobe, or without focal deficit, headache, nausea, or vomiting were more likely to have seizures preoperatively. Logistic regression identified three significant predictors for preoperative seizure: absence of focal deficits at presentation (OR 6.090, 95% CI 3.110-11.925, p<0.001), cortical location (OR 3.834, 95% CI 1.363-10.786, p<0.05) and absence of headache at presentation (OR 2.487, 95% CI 1.139-5.431, p<0.05). The cumulative incidence of seizure was 29% at one year and 32% at 5-year for gliomas. Specifically, the seizure incidence was higher in low-grade gliomas (39% at 1-year) and certain tumor types such as ganglioglioma (50%), oligodendroglioma (48%), and astrocytoma (45%). Conclusion: The cumulative incidence of preoperative seizures in low-grade gliomas and certain tumor types is high. The predictors included cortical involvement and absence of focal neurological deficit or headache at presentation.
目的我们旨在确定胶质瘤患者术前发作的累积发生率、1年和5年发作率，以及预测因素的最新情况。方法：这是一项回顾性分析：这是一项回顾性分析，研究对象是 2008-2020 年间在马来西亚马来亚大学医疗中心接受组织病理学确诊的 239 名胶质瘤患者。采用Kaplan-Meier曲线确定癫痫发作的累积发生率。采用逻辑回归法确定术前癫痫发作的预测因素。结果：共有 80/239 例患者（33.5%）在术前出现癫痫发作。术前癫痫发作更常见于发病年龄较小（40 岁以下为 40.0%，≥40 岁为 26.9%，P<0.05）和低级别肿瘤（42.2%，高级别肿瘤为 28.8%）的患者。皮质（尤其是额叶）受累或无局灶性缺损、头痛、恶心或呕吐的患者术前更有可能出现癫痫发作。逻辑回归确定了术前癫痫发作的三个重要预测因素：发病时无局灶性障碍（OR 6.090，95% CI 3.110-11.925，P<0.001）、皮质位置（OR 3.834，95% CI 1.363-10.786，P<0.05）和发病时无头痛（OR 2.487，95% CI 1.139-5.431，P<0.05）。神经胶质瘤一年期和五年期的癫痫发作累积发生率分别为 29% 和 32%。具体而言，低级别胶质瘤（1年时39%）和某些肿瘤类型（如神经节胶质瘤（50%）、少突胶质瘤（48%）和星形细胞瘤（45%））的癫痫发作发生率较高。结论低级别胶质瘤和某些肿瘤类型术前癫痫发作的累积发生率很高。预测因素包括皮质受累和发病时无局灶性神经功能缺损或头痛。
{"title":"Cumulative seizure occurrence and the predictors of seizure in low- and high-grade gliomas","authors":"Christine Audrey, Kheng Seang Lim, Chet-Ying Chan, Thinisha Sathis Kumar, Rui Jia Hou, Si-Lei Fong, Vairavan Narayanan, Wan Muhammad Afnan Wan Anuar, Chong-Tin Tan","doi":"10.54029/2023swz","DOIUrl":"https://doi.org/10.54029/2023swz","url":null,"abstract":"Objective: We aimed to determine the cumulative seizure occurrence, 1-year, and 5-years of preoperative seizures in gliomas, and an update on the predictors. Methods: This was a retrospective analysis of 239 patients with histopathologically confirmed gliomas in University Malaya Medical Centre, Malaysia, between 2008-2020. Kaplan-Meier curves were used to determine the cumulative incidence of seizures. Logistic regression was performed to determine the predictors of preoperative seizures. Results: A total of 80/239 patients (33.5%) had preoperative seizures. They were more commonly seen in those with younger age of presentation (40.0% in those <40 years old vs. 26.9% in ≥40 years old, p<0.05) and low-grade tumors (42.2% vs. 28.8% in high-grade tumors). Those with cortical involvement, especially the frontal lobe, or without focal deficit, headache, nausea, or vomiting were more likely to have seizures preoperatively. Logistic regression identified three significant predictors for preoperative seizure: absence of focal deficits at presentation (OR 6.090, 95% CI 3.110-11.925, p<0.001), cortical location (OR 3.834, 95% CI 1.363-10.786, p<0.05) and absence of headache at presentation (OR 2.487, 95% CI 1.139-5.431, p<0.05). The cumulative incidence of seizure was 29% at one year and 32% at 5-year for gliomas. Specifically, the seizure incidence was higher in low-grade gliomas (39% at 1-year) and certain tumor types such as ganglioglioma (50%), oligodendroglioma (48%), and astrocytoma (45%). Conclusion: The cumulative incidence of preoperative seizures in low-grade gliomas and certain tumor types is high. The predictors included cortical involvement and absence of focal neurological deficit or headache at presentation.","PeriodicalId":49757,"journal":{"name":"Neurology Asia","volume":"15 5","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139188430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background & Objectives: Stroke-related sarcopenia and language disorder are main sequelae of stroke. The aim of this study is to evaluate the association between language function and body composition characteristics in patients with subacute left hemiplegic stroke. Methods: Body mass index, skeletal muscle index (SMI), and body fat percentage using bioimpedance analysis, hand grip strength, and Medical Research Council (MRC) sum score were evaluated. Language function was evaluated using the Western Aphasia Battery (WAB). A partial correlation analysis was used to assess the relationship between body composition and language function. Results: A total of 54 patients with subacute left hemispheric stroke were enrolled in the study. The aphasia quotient (AQ) of WAB was significantly correlated with SMI, body fat percentage, MRC-sum score, MRC-sum score of unaffected side and hand grip strength. In the multiple regression analysis after adjusting for age and sex, the AQ of WAB was significantly correlated with SMI. Conclusions: Skeletal muscle index showed highest correlation with language function in patients with left hemispheric stroke.
背景与目的：中风相关的肌肉疏松症和语言障碍是中风的主要后遗症。本研究旨在评估亚急性左侧偏瘫中风患者的语言功能与身体成分特征之间的关联。研究方法采用生物阻抗分析法评估体重指数、骨骼肌指数（SMI）和体脂百分比、手部握力和医学研究委员会（MRC）总分。语言功能使用西方失语测试法（WAB）进行评估。采用偏相关分析评估身体成分与语言功能之间的关系。结果共有 54 名亚急性左半球脑卒中患者参加了研究。WAB的失语商数（AQ）与SMI、体脂率、MRC-sum评分、非受影响侧MRC-sum评分和手握力显著相关。在调整年龄和性别后进行的多元回归分析中，WAB 的 AQ 与 SMI 显著相关。结论左侧大脑半球卒中患者的骨骼肌指数与语言功能的相关性最高。
{"title":"Association between language function and body composition characteristics in patients with subacute left hemispheric stroke","authors":"Soo Jeong Han, J. Suh","doi":"10.54029/2023upt","DOIUrl":"https://doi.org/10.54029/2023upt","url":null,"abstract":"Background & Objectives: Stroke-related sarcopenia and language disorder are main sequelae of stroke. The aim of this study is to evaluate the association between language function and body composition characteristics in patients with subacute left hemiplegic stroke. Methods: Body mass index, skeletal muscle index (SMI), and body fat percentage using bioimpedance analysis, hand grip strength, and Medical Research Council (MRC) sum score were evaluated. Language function was evaluated using the Western Aphasia Battery (WAB). A partial correlation analysis was used to assess the relationship between body composition and language function. Results: A total of 54 patients with subacute left hemispheric stroke were enrolled in the study. The aphasia quotient (AQ) of WAB was significantly correlated with SMI, body fat percentage, MRC-sum score, MRC-sum score of unaffected side and hand grip strength. In the multiple regression analysis after adjusting for age and sex, the AQ of WAB was significantly correlated with SMI. Conclusions: Skeletal muscle index showed highest correlation with language function in patients with left hemispheric stroke.","PeriodicalId":49757,"journal":{"name":"Neurology Asia","volume":"13 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139192259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background & Objective: The mean platelet volume-to-lymphocyte ratio (MPVLR) is a novel and easily available marker of poor short-term prognosis in myocardial infarction patients. The present study was to investigate the association between MPVLR and clinical outcome of patients with acute ischemic stroke. Methods: A total of 494 acute ischemic stroke patients were included in this study and received 3-months follow-up. Blood samples for MPVLR were obtained at admission and at 7 days after acute ischemic stroke. Poor functional outcome was defined as a modified Rankin Scale (mRS) score of 3-6 at 3 months after stroke. Results: Compared with good prognosis group, MPVLR level at admission and at 7 days in poor prognosis group was significantly higher, the difference between these two groups was statistically significant (P < 0.001). In multivariate logistic regression analysis, both MPVLR as a continuous (OR 1.13; 95%CI, 1.064-1.190, P=0.001) and categorical variable (OR 3.05; 95%CI, 1.85-5.05, P<0.001) were independently associated with poor outcome at 3 months. ROC analysis revealed the predictive value of MPVLR was better than that of platelet-to lymphocyte ratio (PLR). The nomogram was used for predicting 3-months unfavourable outcome after an acute ischemic stroke. Conclusions: MPVLR at admission and at 7 days after stroke were found to be independently associated with poor functional outcome. MPVLR may serve as an activity marker for poor prognosis in patients with acute ischemic stroke.
{"title":"Mean platelet volume-to-lymphocyte ratio predicts poor functional outcome of acute ischemic stroke patients","authors":"Anna Ying, Yiqing Jiang, Lingyan Chen","doi":"10.54029/2023thw","DOIUrl":"https://doi.org/10.54029/2023thw","url":null,"abstract":"Background & Objective: The mean platelet volume-to-lymphocyte ratio (MPVLR) is a novel and easily available marker of poor short-term prognosis in myocardial infarction patients. The present study was to investigate the association between MPVLR and clinical outcome of patients with acute ischemic stroke. Methods: A total of 494 acute ischemic stroke patients were included in this study and received 3-months follow-up. Blood samples for MPVLR were obtained at admission and at 7 days after acute ischemic stroke. Poor functional outcome was defined as a modified Rankin Scale (mRS) score of 3-6 at 3 months after stroke. Results: Compared with good prognosis group, MPVLR level at admission and at 7 days in poor prognosis group was significantly higher, the difference between these two groups was statistically significant (P < 0.001). In multivariate logistic regression analysis, both MPVLR as a continuous (OR 1.13; 95%CI, 1.064-1.190, P=0.001) and categorical variable (OR 3.05; 95%CI, 1.85-5.05, P<0.001) were independently associated with poor outcome at 3 months. ROC analysis revealed the predictive value of MPVLR was better than that of platelet-to lymphocyte ratio (PLR). The nomogram was used for predicting 3-months unfavourable outcome after an acute ischemic stroke. Conclusions: MPVLR at admission and at 7 days after stroke were found to be independently associated with poor functional outcome. MPVLR may serve as an activity marker for poor prognosis in patients with acute ischemic stroke.","PeriodicalId":49757,"journal":{"name":"Neurology Asia","volume":"39 7","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139191166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background & Objective: Personality traits are associated with mental health and quality of life in patients with multiple sclerosis (MS). The aim of this study was to determine personality traits in patients with MS and to examine the relationship between these traits and stigmatization, depression and quality of life. Method: This descriptive, cross-sectional study included 80 MS patients and 96 healthy controls. Data were collected online between June and July 2022. Patient/person information form, Eysenck Personality Questionnaire Revised-Short Form (EPQ-RS), Neuro Quality of Life-Stigma Scale, Beck Depression Inventory and MS Quality of Life Scale-54 were used for data collection. Results: When the age variable was controlled, it was found that the mean neuroticism subscale score was higher (p=0.003) and the mean extraversion subscale score was lower (p=0.018) than the control group. In addition, the mean extraversion score was found to be negatively correlated with stigmatization (p<0.05) and depression (p<0.01), and positively correlated with the physical sub-dimension of quality of life (p<0.01). Neuroticism and psychoticism sub-dimensions were positively correlated with stigmatization and depression and negatively correlated with all sub-dimensions of quality of life (p<0.01). In addition, regression analysis showed that depression significantly contributed to the physical health dimension of quality of life and neuroticism personality trait significantly contributed to the mental health dimension. Conclusions: Neurotic personality traits were found to be more dominant in patients with MS. Moreover, all sub-dimensions of personality traits were associated with stigmatization, depression and quality of life. Therefore, personality traits should be considered in interventions to improve mental health and quality of life.
{"title":"Relationship of personality traits with stigmatization, depression, and quality of life in patients with multiple sclerosis","authors":"Kubra Yeni, Murat Terzi","doi":"10.54029/2023mkx","DOIUrl":"https://doi.org/10.54029/2023mkx","url":null,"abstract":"Background & Objective: Personality traits are associated with mental health and quality of life in patients with multiple sclerosis (MS). The aim of this study was to determine personality traits in patients with MS and to examine the relationship between these traits and stigmatization, depression and quality of life. Method: This descriptive, cross-sectional study included 80 MS patients and 96 healthy controls. Data were collected online between June and July 2022. Patient/person information form, Eysenck Personality Questionnaire Revised-Short Form (EPQ-RS), Neuro Quality of Life-Stigma Scale, Beck Depression Inventory and MS Quality of Life Scale-54 were used for data collection. Results: When the age variable was controlled, it was found that the mean neuroticism subscale score was higher (p=0.003) and the mean extraversion subscale score was lower (p=0.018) than the control group. In addition, the mean extraversion score was found to be negatively correlated with stigmatization (p<0.05) and depression (p<0.01), and positively correlated with the physical sub-dimension of quality of life (p<0.01). Neuroticism and psychoticism sub-dimensions were positively correlated with stigmatization and depression and negatively correlated with all sub-dimensions of quality of life (p<0.01). In addition, regression analysis showed that depression significantly contributed to the physical health dimension of quality of life and neuroticism personality trait significantly contributed to the mental health dimension. Conclusions: Neurotic personality traits were found to be more dominant in patients with MS. Moreover, all sub-dimensions of personality traits were associated with stigmatization, depression and quality of life. Therefore, personality traits should be considered in interventions to improve mental health and quality of life.","PeriodicalId":49757,"journal":{"name":"Neurology Asia","volume":"82 1-2","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139195157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zafer Ercan, Sena Boncuk Ulaş, B. Acar, T. Acar, H. Dheir, Yeşim Güzey Aras, Mahmudul Islam, Alper Eryilmaz, Şule Dalkiliç, Ayşe POLAT ZAFER, Nimet UÇAROĞLU CAN
Background & Objective: Chronic kidney disease (CKD) is associated with increased mortality risk in acute stroke patients. This study aims to investigate potential association between CKD and the prognosis of endovascular treated acute ischemic stroke patients. Methods: Patients with endovascular treatment (EVT) for acute ischemic stroke were studied retrospectively in a comprehensive stroke center. Patients were classified as pre-procedural CKD and non-CKD. The groups were compared regarding demographic data, procedural data, and outcomes. Results: A total of 140 patients (69 male, 49.3%) with a mean age of 66.51±11.8 were involved in the study. Symptomatic intracranial hemorrhage in the first 24 hours and mortality in three months were increased in the CKD group (50% vs. 19.8; p=0.001). Excellent and good outcomes were decreased in the CKD group (25% vs. 53.4; p=0.01 and 41.6% vs. 56.9%; p=0.03). Multiple logistic regression adjusted for potential confounders demonstrated that CKD was associated with lower rates of excellent outcome (odds ratio [OR] = 0.50, 95% confidence interval [CI], 0.25 to 0.80, p = 0.01), higher mRS scores (common OR = 1.82, 95% CI, 1.2 to 2.9, p = 0.01), and increased mortality (OR = 2.1, 95% CI, 1.2 to 4.2, p = 0.01) and sICH (OR = 1.15, 95% CI, 1.03 to 3.4, P = 0.04) Conclusion: There is an association between CKD and poorer results in patients with acute ischemic stroke treated with EVT. The presence of CKD should not prohibit patients from undergoing EVT, but taking baseline eGFR into account may improve estimation of prognosis and help decision-making in treatment modality.
{"title":"Can eGFR be a prognostic factor for endovascular therapy for acute ischemic stroke?","authors":"Zafer Ercan, Sena Boncuk Ulaş, B. Acar, T. Acar, H. Dheir, Yeşim Güzey Aras, Mahmudul Islam, Alper Eryilmaz, Şule Dalkiliç, Ayşe POLAT ZAFER, Nimet UÇAROĞLU CAN","doi":"10.54029/2023ryi","DOIUrl":"https://doi.org/10.54029/2023ryi","url":null,"abstract":"Background & Objective: Chronic kidney disease (CKD) is associated with increased mortality risk in acute stroke patients. This study aims to investigate potential association between CKD and the prognosis of endovascular treated acute ischemic stroke patients. Methods: Patients with endovascular treatment (EVT) for acute ischemic stroke were studied retrospectively in a comprehensive stroke center. Patients were classified as pre-procedural CKD and non-CKD. The groups were compared regarding demographic data, procedural data, and outcomes. Results: A total of 140 patients (69 male, 49.3%) with a mean age of 66.51±11.8 were involved in the study. Symptomatic intracranial hemorrhage in the first 24 hours and mortality in three months were increased in the CKD group (50% vs. 19.8; p=0.001). Excellent and good outcomes were decreased in the CKD group (25% vs. 53.4; p=0.01 and 41.6% vs. 56.9%; p=0.03). Multiple logistic regression adjusted for potential confounders demonstrated that CKD was associated with lower rates of excellent outcome (odds ratio [OR] = 0.50, 95% confidence interval [CI], 0.25 to 0.80, p = 0.01), higher mRS scores (common OR = 1.82, 95% CI, 1.2 to 2.9, p = 0.01), and increased mortality (OR = 2.1, 95% CI, 1.2 to 4.2, p = 0.01) and sICH (OR = 1.15, 95% CI, 1.03 to 3.4, P = 0.04) Conclusion: There is an association between CKD and poorer results in patients with acute ischemic stroke treated with EVT. The presence of CKD should not prohibit patients from undergoing EVT, but taking baseline eGFR into account may improve estimation of prognosis and help decision-making in treatment modality.","PeriodicalId":49757,"journal":{"name":"Neurology Asia","volume":"57 26","pages":""},"PeriodicalIF":0.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139196376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：